Dr. Cheng-Yao Chen, CEO of YD BioLabs, was invited by the Department of Medical Genetics at National Taiwan University to share insights on the company’s proprietary enzymatic DNA synthesis technology. In his talk, Dr. Chen discussed how YD BioLabs is advancing nucleic acid innovation for research and clinical applications, and the potential of integrating DNA read-and-write systems for the future of biotechnology.
